nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylic acid—PTGS2—urinary bladder cancer	0.28	1	CbGaD
Salicylic acid—SLC16A1—Methotrexate—urinary bladder cancer	0.0796	0.147	CbGbCtD
Salicylic acid—SLC22A7—Fluorouracil—urinary bladder cancer	0.071	0.131	CbGbCtD
Salicylic acid—ABCB1—Mitomycin—urinary bladder cancer	0.0547	0.101	CbGbCtD
Salicylic acid—SLC22A11—Methotrexate—urinary bladder cancer	0.0411	0.0758	CbGbCtD
Salicylic acid—SLC22A7—Methotrexate—urinary bladder cancer	0.0392	0.0722	CbGbCtD
Salicylic acid—PTGS2—Cisplatin—urinary bladder cancer	0.0346	0.0639	CbGbCtD
Salicylic acid—PTGS2—Etoposide—urinary bladder cancer	0.034	0.0627	CbGbCtD
Salicylic acid—PTGS1—Etoposide—urinary bladder cancer	0.0287	0.053	CbGbCtD
Salicylic acid—ALB—Fluorouracil—urinary bladder cancer	0.0257	0.0474	CbGbCtD
Salicylic acid—SLC22A8—Methotrexate—urinary bladder cancer	0.0239	0.0441	CbGbCtD
Salicylic acid—SLC22A6—Methotrexate—urinary bladder cancer	0.0167	0.0307	CbGbCtD
Salicylic acid—ABCB1—Gemcitabine—urinary bladder cancer	0.0157	0.029	CbGbCtD
Salicylic acid—ALB—Methotrexate—urinary bladder cancer	0.0142	0.0261	CbGbCtD
Salicylic acid—CYP2C9—Fluorouracil—urinary bladder cancer	0.0139	0.0256	CbGbCtD
Salicylic acid—CYP2C9—Cisplatin—urinary bladder cancer	0.0118	0.0217	CbGbCtD
Salicylic acid—ABCB1—Cisplatin—urinary bladder cancer	0.0114	0.0211	CbGbCtD
Salicylic acid—ABCB1—Etoposide—urinary bladder cancer	0.0112	0.0207	CbGbCtD
Salicylic acid—ABCB1—Doxorubicin—urinary bladder cancer	0.00766	0.0141	CbGbCtD
Salicylic acid—ABCB1—Methotrexate—urinary bladder cancer	0.00742	0.0137	CbGbCtD
Salicylic acid—SLC22A8—urine—urinary bladder cancer	0.00369	0.107	CbGeAlD
Salicylic acid—Burning sensation—Mitomycin—urinary bladder cancer	0.003	0.0367	CcSEcCtD
Salicylic acid—Stinging—Mitomycin—urinary bladder cancer	0.00257	0.0315	CcSEcCtD
Salicylic acid—CYP2C9—urine—urinary bladder cancer	0.0024	0.0697	CbGeAlD
Salicylic acid—SLC16A1—prostate gland—urinary bladder cancer	0.00175	0.0509	CbGeAlD
Salicylic acid—SLC22A11—renal system—urinary bladder cancer	0.0016	0.0465	CbGeAlD
Salicylic acid—SLC22A7—renal system—urinary bladder cancer	0.00156	0.0454	CbGeAlD
Salicylic acid—SLCO2B1—prostate gland—urinary bladder cancer	0.00151	0.0438	CbGeAlD
Salicylic acid—SLC22A8—prostate gland—urinary bladder cancer	0.00133	0.0385	CbGeAlD
Salicylic acid—SLC16A1—epithelium—urinary bladder cancer	0.00129	0.0374	CbGeAlD
Salicylic acid—SLC22A11—female reproductive system—urinary bladder cancer	0.00128	0.0372	CbGeAlD
Salicylic acid—Heartburn—Fluorouracil—urinary bladder cancer	0.00126	0.0154	CcSEcCtD
Salicylic acid—SLC16A1—renal system—urinary bladder cancer	0.00119	0.0347	CbGeAlD
Salicylic acid—Drowsiness—Mitomycin—urinary bladder cancer	0.00117	0.0143	CcSEcCtD
Salicylic acid—Acetylsalicylic acid—TP53—urinary bladder cancer	0.00114	0.185	CrCbGaD
Salicylic acid—Hearing impaired—Thiotepa—urinary bladder cancer	0.0011	0.0135	CcSEcCtD
Salicylic acid—Stinging—Fluorouracil—urinary bladder cancer	0.00107	0.0131	CcSEcCtD
Salicylic acid—SLCO2B1—renal system—urinary bladder cancer	0.00103	0.0299	CbGeAlD
Salicylic acid—Skin exfoliation—Thiotepa—urinary bladder cancer	0.001	0.0122	CcSEcCtD
Salicylic acid—Oesophagitis—Thiotepa—urinary bladder cancer	0.000958	0.0117	CcSEcCtD
Salicylic acid—SLC16A1—female reproductive system—urinary bladder cancer	0.000957	0.0278	CbGeAlD
Salicylic acid—Hearing impaired—Gemcitabine—urinary bladder cancer	0.000926	0.0113	CcSEcCtD
Salicylic acid—Erythema—Mitomycin—urinary bladder cancer	0.000911	0.0112	CcSEcCtD
Salicylic acid—SLC22A8—renal system—urinary bladder cancer	0.000903	0.0262	CbGeAlD
Salicylic acid—Feeling abnormal—Valrubicin—urinary bladder cancer	0.000889	0.0109	CcSEcCtD
Salicylic acid—Aminosalicylic Acid—MPO—urinary bladder cancer	0.000882	0.143	CrCbGaD
Salicylic acid—Hearing impaired—Cisplatin—urinary bladder cancer	0.000863	0.0106	CcSEcCtD
Salicylic acid—Pain—Carboplatin—urinary bladder cancer	0.000855	0.0105	CcSEcCtD
Salicylic acid—Deafness—Thiotepa—urinary bladder cancer	0.000851	0.0104	CcSEcCtD
Salicylic acid—Skin exfoliation—Gemcitabine—urinary bladder cancer	0.000842	0.0103	CcSEcCtD
Salicylic acid—SLCO2B1—female reproductive system—urinary bladder cancer	0.000823	0.0239	CbGeAlD
Salicylic acid—Oesophagitis—Fluorouracil—urinary bladder cancer	0.000792	0.0097	CcSEcCtD
Salicylic acid—PTGS1—prostate gland—urinary bladder cancer	0.000786	0.0228	CbGeAlD
Salicylic acid—Skin exfoliation—Cisplatin—urinary bladder cancer	0.000785	0.0096	CcSEcCtD
Salicylic acid—Pruritus—Valrubicin—urinary bladder cancer	0.000764	0.00935	CcSEcCtD
Salicylic acid—PTGS2—prostate gland—urinary bladder cancer	0.000752	0.0218	CbGeAlD
Salicylic acid—Confusional state—Mitomycin—urinary bladder cancer	0.00075	0.00918	CcSEcCtD
Salicylic acid—Oedema—Mitomycin—urinary bladder cancer	0.000744	0.0091	CcSEcCtD
Salicylic acid—Diarrhoea—Valrubicin—urinary bladder cancer	0.000739	0.00904	CcSEcCtD
Salicylic acid—Gastric ulcer—Epirubicin—urinary bladder cancer	0.000726	0.00889	CcSEcCtD
Salicylic acid—Skin exfoliation—Etoposide—urinary bladder cancer	0.000719	0.0088	CcSEcCtD
Salicylic acid—Deafness—Gemcitabine—urinary bladder cancer	0.000715	0.00876	CcSEcCtD
Salicylic acid—Dizziness—Valrubicin—urinary bladder cancer	0.000714	0.00874	CcSEcCtD
Salicylic acid—Anorexia—Mitomycin—urinary bladder cancer	0.000709	0.00868	CcSEcCtD
Salicylic acid—Mesalazine—MPO—urinary bladder cancer	0.000692	0.112	CrCbGaD
Salicylic acid—Oesophagitis—Etoposide—urinary bladder cancer	0.000688	0.00842	CcSEcCtD
Salicylic acid—Vomiting—Valrubicin—urinary bladder cancer	0.000686	0.0084	CcSEcCtD
Salicylic acid—Rash—Valrubicin—urinary bladder cancer	0.000681	0.00833	CcSEcCtD
Salicylic acid—Dermatitis—Valrubicin—urinary bladder cancer	0.00068	0.00832	CcSEcCtD
Salicylic acid—Headache—Valrubicin—urinary bladder cancer	0.000676	0.00828	CcSEcCtD
Salicylic acid—Gastric ulcer—Doxorubicin—urinary bladder cancer	0.000672	0.00823	CcSEcCtD
Salicylic acid—Deafness—Cisplatin—urinary bladder cancer	0.000667	0.00816	CcSEcCtD
Salicylic acid—PTGS1—seminal vesicle—urinary bladder cancer	0.000665	0.0193	CbGeAlD
Salicylic acid—Somnolence—Mitomycin—urinary bladder cancer	0.000661	0.00809	CcSEcCtD
Salicylic acid—Burning sensation—Methotrexate—urinary bladder cancer	0.000649	0.00795	CcSEcCtD
Salicylic acid—Decreased appetite—Mitomycin—urinary bladder cancer	0.000646	0.00791	CcSEcCtD
Salicylic acid—Lethargy—Fluorouracil—urinary bladder cancer	0.000642	0.00786	CcSEcCtD
Salicylic acid—Nausea—Valrubicin—urinary bladder cancer	0.000641	0.00785	CcSEcCtD
Salicylic acid—Pain—Mitomycin—urinary bladder cancer	0.000636	0.00778	CcSEcCtD
Salicylic acid—PTGS2—seminal vesicle—urinary bladder cancer	0.000636	0.0185	CbGeAlD
Salicylic acid—Mesalazine—PPARG—urinary bladder cancer	0.000615	0.0997	CrCbGaD
Salicylic acid—Feeling abnormal—Mitomycin—urinary bladder cancer	0.000613	0.0075	CcSEcCtD
Salicylic acid—Burning sensation—Epirubicin—urinary bladder cancer	0.000607	0.00744	CcSEcCtD
Salicylic acid—Weight increased—Thiotepa—urinary bladder cancer	0.000598	0.00733	CcSEcCtD
Salicylic acid—PTGS1—epithelium—urinary bladder cancer	0.000578	0.0168	CbGeAlD
Salicylic acid—Burning sensation—Doxorubicin—urinary bladder cancer	0.000562	0.00688	CcSEcCtD
Salicylic acid—SLC16A1—lymph node—urinary bladder cancer	0.00056	0.0163	CbGeAlD
Salicylic acid—PTGS1—smooth muscle tissue—urinary bladder cancer	0.000557	0.0162	CbGeAlD
Salicylic acid—Epistaxis—Thiotepa—urinary bladder cancer	0.000553	0.00677	CcSEcCtD
Salicylic acid—PTGS2—epithelium—urinary bladder cancer	0.000552	0.016	CbGeAlD
Salicylic acid—PTGS1—renal system—urinary bladder cancer	0.000536	0.0156	CbGeAlD
Salicylic acid—PTGS2—smooth muscle tissue—urinary bladder cancer	0.000532	0.0155	CbGeAlD
Salicylic acid—Hallucination—Thiotepa—urinary bladder cancer	0.000524	0.00641	CcSEcCtD
Salicylic acid—Stinging—Epirubicin—urinary bladder cancer	0.000521	0.00638	CcSEcCtD
Salicylic acid—Salicylate-sodium—PTGS2—urinary bladder cancer	0.000513	0.0833	CrCbGaD
Salicylic acid—PTGS2—renal system—urinary bladder cancer	0.000512	0.0149	CbGeAlD
Salicylic acid—Diarrhoea—Mitomycin—urinary bladder cancer	0.000509	0.00623	CcSEcCtD
Salicylic acid—PTGS2—urethra—urinary bladder cancer	0.000503	0.0146	CbGeAlD
Salicylic acid—Abdominal discomfort—Cisplatin—urinary bladder cancer	0.000494	0.00605	CcSEcCtD
Salicylic acid—Dizziness—Mitomycin—urinary bladder cancer	0.000492	0.00602	CcSEcCtD
Salicylic acid—Tinnitus—Thiotepa—urinary bladder cancer	0.000491	0.00601	CcSEcCtD
Salicylic acid—Stinging—Doxorubicin—urinary bladder cancer	0.000482	0.0059	CcSEcCtD
Salicylic acid—SLCO2B1—lymph node—urinary bladder cancer	0.000482	0.014	CbGeAlD
Salicylic acid—Vomiting—Mitomycin—urinary bladder cancer	0.000473	0.00579	CcSEcCtD
Salicylic acid—CYP2C9—female reproductive system—urinary bladder cancer	0.00047	0.0137	CbGeAlD
Salicylic acid—Rash—Mitomycin—urinary bladder cancer	0.000469	0.00574	CcSEcCtD
Salicylic acid—Dermatitis—Mitomycin—urinary bladder cancer	0.000468	0.00573	CcSEcCtD
Salicylic acid—Headache—Mitomycin—urinary bladder cancer	0.000466	0.0057	CcSEcCtD
Salicylic acid—ABCB1—prostate gland—urinary bladder cancer	0.000465	0.0135	CbGeAlD
Salicylic acid—Erythema—Thiotepa—urinary bladder cancer	0.000458	0.00561	CcSEcCtD
Salicylic acid—Epistaxis—Fluorouracil—urinary bladder cancer	0.000457	0.0056	CcSEcCtD
Salicylic acid—Nausea—Mitomycin—urinary bladder cancer	0.000442	0.00541	CcSEcCtD
Salicylic acid—ALB—lymph node—urinary bladder cancer	0.000441	0.0128	CbGeAlD
Salicylic acid—Skin exfoliation—Methotrexate—urinary bladder cancer	0.000431	0.00527	CcSEcCtD
Salicylic acid—PTGS1—female reproductive system—urinary bladder cancer	0.000429	0.0125	CbGeAlD
Salicylic acid—Erythema multiforme—Gemcitabine—urinary bladder cancer	0.000419	0.00512	CcSEcCtD
Salicylic acid—PTGS2—female reproductive system—urinary bladder cancer	0.00041	0.0119	CbGeAlD
Salicylic acid—Ecchymosis—Methotrexate—urinary bladder cancer	0.000408	0.00499	CcSEcCtD
Salicylic acid—Skin exfoliation—Epirubicin—urinary bladder cancer	0.000403	0.00493	CcSEcCtD
Salicylic acid—ABCB1—seminal vesicle—urinary bladder cancer	0.000393	0.0114	CbGeAlD
Salicylic acid—PTGS1—vagina—urinary bladder cancer	0.000388	0.0113	CbGeAlD
Salicylic acid—Oesophagitis—Epirubicin—urinary bladder cancer	0.000386	0.00472	CcSEcCtD
Salicylic acid—Erythema—Gemcitabine—urinary bladder cancer	0.000385	0.00472	CcSEcCtD
Salicylic acid—Tinnitus—Cisplatin—urinary bladder cancer	0.000385	0.00471	CcSEcCtD
Salicylic acid—Ecchymosis—Epirubicin—urinary bladder cancer	0.000382	0.00467	CcSEcCtD
Salicylic acid—Erythema—Fluorouracil—urinary bladder cancer	0.000379	0.00464	CcSEcCtD
Salicylic acid—Confusional state—Thiotepa—urinary bladder cancer	0.000377	0.00462	CcSEcCtD
Salicylic acid—Skin exfoliation—Doxorubicin—urinary bladder cancer	0.000373	0.00456	CcSEcCtD
Salicylic acid—PTGS2—vagina—urinary bladder cancer	0.000371	0.0108	CbGeAlD
Salicylic acid—Erythema—Cisplatin—urinary bladder cancer	0.000359	0.0044	CcSEcCtD
Salicylic acid—Erythema multiforme—Etoposide—urinary bladder cancer	0.000357	0.00438	CcSEcCtD
Salicylic acid—Oesophagitis—Doxorubicin—urinary bladder cancer	0.000357	0.00437	CcSEcCtD
Salicylic acid—Anorexia—Thiotepa—urinary bladder cancer	0.000356	0.00436	CcSEcCtD
Salicylic acid—Ecchymosis—Doxorubicin—urinary bladder cancer	0.000353	0.00432	CcSEcCtD
Salicylic acid—Magnesium salicylate—PTGS2—urinary bladder cancer	0.000352	0.0571	CrCbGaD
Salicylic acid—ABCB1—epithelium—urinary bladder cancer	0.000342	0.00992	CbGeAlD
Salicylic acid—Lethargy—Methotrexate—urinary bladder cancer	0.000334	0.00409	CcSEcCtD
Salicylic acid—Somnolence—Thiotepa—urinary bladder cancer	0.000332	0.00407	CcSEcCtD
Salicylic acid—Aminosalicylic Acid—PTGS2—urinary bladder cancer	0.000331	0.0537	CrCbGaD
Salicylic acid—Diflunisal—PTGS2—urinary bladder cancer	0.000331	0.0537	CrCbGaD
Salicylic acid—Dyspepsia—Thiotepa—urinary bladder cancer	0.000329	0.00403	CcSEcCtD
Salicylic acid—Decreased appetite—Thiotepa—urinary bladder cancer	0.000325	0.00398	CcSEcCtD
Salicylic acid—Dysgeusia—Etoposide—urinary bladder cancer	0.000322	0.00395	CcSEcCtD
Salicylic acid—Pain—Thiotepa—urinary bladder cancer	0.00032	0.00391	CcSEcCtD
Salicylic acid—Constipation—Thiotepa—urinary bladder cancer	0.00032	0.00391	CcSEcCtD
Salicylic acid—ABCB1—renal system—urinary bladder cancer	0.000317	0.0092	CbGeAlD
Salicylic acid—Oedema—Gemcitabine—urinary bladder cancer	0.000315	0.00385	CcSEcCtD
Salicylic acid—Lethargy—Epirubicin—urinary bladder cancer	0.000313	0.00383	CcSEcCtD
Salicylic acid—Confusional state—Fluorouracil—urinary bladder cancer	0.000312	0.00382	CcSEcCtD
Salicylic acid—ABCB1—urethra—urinary bladder cancer	0.000311	0.00904	CbGeAlD
Salicylic acid—Oedema—Fluorouracil—urinary bladder cancer	0.000309	0.00379	CcSEcCtD
Salicylic acid—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000308	0.00377	CcSEcCtD
Salicylic acid—Anorexia—Gemcitabine—urinary bladder cancer	0.0003	0.00367	CcSEcCtD
Salicylic acid—Salsalate—PTGS2—urinary bladder cancer	0.000299	0.0485	CrCbGaD
Salicylic acid—Urticaria—Thiotepa—urinary bladder cancer	0.000297	0.00364	CcSEcCtD
Salicylic acid—Anorexia—Fluorouracil—urinary bladder cancer	0.000295	0.00361	CcSEcCtD
Salicylic acid—Meclofenamic acid—PTGS2—urinary bladder cancer	0.000295	0.0478	CrCbGaD
Salicylic acid—Oedema—Cisplatin—urinary bladder cancer	0.000293	0.00359	CcSEcCtD
Salicylic acid—Lethargy—Doxorubicin—urinary bladder cancer	0.000289	0.00354	CcSEcCtD
Salicylic acid—Asthma—Methotrexate—urinary bladder cancer	0.000283	0.00346	CcSEcCtD
Salicylic acid—Abdominal pain upper—Epirubicin—urinary bladder cancer	0.00028	0.00343	CcSEcCtD
Salicylic acid—Somnolence—Gemcitabine—urinary bladder cancer	0.00028	0.00342	CcSEcCtD
Salicylic acid—Anorexia—Cisplatin—urinary bladder cancer	0.000279	0.00342	CcSEcCtD
Salicylic acid—Somnolence—Fluorouracil—urinary bladder cancer	0.000275	0.00337	CcSEcCtD
Salicylic acid—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000273	0.00335	CcSEcCtD
Salicylic acid—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000272	0.00333	CcSEcCtD
Salicylic acid—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.000271	0.00332	CcSEcCtD
Salicylic acid—Confusional state—Etoposide—urinary bladder cancer	0.000271	0.00332	CcSEcCtD
Salicylic acid—Constipation—Gemcitabine—urinary bladder cancer	0.000269	0.00329	CcSEcCtD
Salicylic acid—Pain—Gemcitabine—urinary bladder cancer	0.000269	0.00329	CcSEcCtD
Salicylic acid—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000269	0.00329	CcSEcCtD
Salicylic acid—Asthma—Epirubicin—urinary bladder cancer	0.000265	0.00324	CcSEcCtD
Salicylic acid—Pruritus—Thiotepa—urinary bladder cancer	0.000265	0.00324	CcSEcCtD
Salicylic acid—Pain—Fluorouracil—urinary bladder cancer	0.000264	0.00324	CcSEcCtD
Salicylic acid—Mesalazine—PTGS2—urinary bladder cancer	0.000259	0.0421	CrCbGaD
Salicylic acid—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000259	0.00317	CcSEcCtD
Salicylic acid—Abdominal pain upper—Doxorubicin—urinary bladder cancer	0.000259	0.00317	CcSEcCtD
Salicylic acid—Anorexia—Etoposide—urinary bladder cancer	0.000256	0.00313	CcSEcCtD
Salicylic acid—Diarrhoea—Thiotepa—urinary bladder cancer	0.000256	0.00313	CcSEcCtD
Salicylic acid—Decreased appetite—Cisplatin—urinary bladder cancer	0.000255	0.00312	CcSEcCtD
Salicylic acid—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000255	0.00312	CcSEcCtD
Salicylic acid—ABCB1—female reproductive system—urinary bladder cancer	0.000254	0.00737	CbGeAlD
Salicylic acid—Drowsiness—Methotrexate—urinary bladder cancer	0.000252	0.00309	CcSEcCtD
Salicylic acid—PTGS1—lymph node—urinary bladder cancer	0.000251	0.00729	CbGeAlD
Salicylic acid—Pain—Cisplatin—urinary bladder cancer	0.000251	0.00307	CcSEcCtD
Salicylic acid—Dizziness—Thiotepa—urinary bladder cancer	0.000247	0.00303	CcSEcCtD
Salicylic acid—Urticaria—Fluorouracil—urinary bladder cancer	0.000246	0.00301	CcSEcCtD
Salicylic acid—Asthma—Doxorubicin—urinary bladder cancer	0.000245	0.003	CcSEcCtD
Salicylic acid—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000242	0.00296	CcSEcCtD
Salicylic acid—Weight increased—Epirubicin—urinary bladder cancer	0.000241	0.00295	CcSEcCtD
Salicylic acid—PTGS2—lymph node—urinary bladder cancer	0.00024	0.00697	CbGeAlD
Salicylic acid—Somnolence—Etoposide—urinary bladder cancer	0.000239	0.00292	CcSEcCtD
Salicylic acid—Epistaxis—Methotrexate—urinary bladder cancer	0.000238	0.00291	CcSEcCtD
Salicylic acid—Vomiting—Thiotepa—urinary bladder cancer	0.000238	0.00291	CcSEcCtD
Salicylic acid—Drowsiness—Epirubicin—urinary bladder cancer	0.000236	0.00289	CcSEcCtD
Salicylic acid—Rash—Thiotepa—urinary bladder cancer	0.000236	0.00289	CcSEcCtD
Salicylic acid—Dermatitis—Thiotepa—urinary bladder cancer	0.000236	0.00288	CcSEcCtD
Salicylic acid—Headache—Thiotepa—urinary bladder cancer	0.000234	0.00287	CcSEcCtD
Salicylic acid—Decreased appetite—Etoposide—urinary bladder cancer	0.000234	0.00286	CcSEcCtD
Salicylic acid—Constipation—Etoposide—urinary bladder cancer	0.00023	0.00281	CcSEcCtD
Salicylic acid—Pain—Etoposide—urinary bladder cancer	0.00023	0.00281	CcSEcCtD
Salicylic acid—ABCB1—vagina—urinary bladder cancer	0.00023	0.00667	CbGeAlD
Salicylic acid—Mefenamic acid—PTGS2—urinary bladder cancer	0.000229	0.0372	CrCbGaD
Salicylic acid—Hepatitis—Methotrexate—urinary bladder cancer	0.000226	0.00277	CcSEcCtD
Salicylic acid—Acetylsalicylic acid—PTGS2—urinary bladder cancer	0.000223	0.0362	CrCbGaD
Salicylic acid—Weight increased—Doxorubicin—urinary bladder cancer	0.000223	0.00273	CcSEcCtD
Salicylic acid—Epistaxis—Epirubicin—urinary bladder cancer	0.000223	0.00273	CcSEcCtD
Salicylic acid—Pruritus—Gemcitabine—urinary bladder cancer	0.000223	0.00272	CcSEcCtD
Salicylic acid—Nausea—Thiotepa—urinary bladder cancer	0.000222	0.00272	CcSEcCtD
Salicylic acid—Feeling abnormal—Etoposide—urinary bladder cancer	0.000221	0.00271	CcSEcCtD
Salicylic acid—Pruritus—Fluorouracil—urinary bladder cancer	0.000219	0.00268	CcSEcCtD
Salicylic acid—Drowsiness—Doxorubicin—urinary bladder cancer	0.000218	0.00267	CcSEcCtD
Salicylic acid—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000215	0.00263	CcSEcCtD
Salicylic acid—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000214	0.00262	CcSEcCtD
Salicylic acid—Urticaria—Etoposide—urinary bladder cancer	0.000213	0.00261	CcSEcCtD
Salicylic acid—Hepatitis—Epirubicin—urinary bladder cancer	0.000212	0.00259	CcSEcCtD
Salicylic acid—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000212	0.00259	CcSEcCtD
Salicylic acid—Tinnitus—Methotrexate—urinary bladder cancer	0.000211	0.00258	CcSEcCtD
Salicylic acid—Epistaxis—Doxorubicin—urinary bladder cancer	0.000206	0.00252	CcSEcCtD
Salicylic acid—Dizziness—Fluorouracil—urinary bladder cancer	0.000205	0.0025	CcSEcCtD
Salicylic acid—Diarrhoea—Cisplatin—urinary bladder cancer	0.000201	0.00246	CcSEcCtD
Salicylic acid—Erythema multiforme—Epirubicin—urinary bladder cancer	0.0002	0.00245	CcSEcCtD
Salicylic acid—Vomiting—Gemcitabine—urinary bladder cancer	0.0002	0.00245	CcSEcCtD
Salicylic acid—Rash—Gemcitabine—urinary bladder cancer	0.000198	0.00243	CcSEcCtD
Salicylic acid—Dermatitis—Gemcitabine—urinary bladder cancer	0.000198	0.00243	CcSEcCtD
Salicylic acid—Tinnitus—Epirubicin—urinary bladder cancer	0.000198	0.00242	CcSEcCtD
Salicylic acid—Erythema—Methotrexate—urinary bladder cancer	0.000197	0.00241	CcSEcCtD
Salicylic acid—Headache—Gemcitabine—urinary bladder cancer	0.000197	0.00241	CcSEcCtD
Salicylic acid—Vomiting—Fluorouracil—urinary bladder cancer	0.000197	0.00241	CcSEcCtD
Salicylic acid—Hepatitis—Doxorubicin—urinary bladder cancer	0.000196	0.0024	CcSEcCtD
Salicylic acid—Rash—Fluorouracil—urinary bladder cancer	0.000195	0.00239	CcSEcCtD
Salicylic acid—Dermatitis—Fluorouracil—urinary bladder cancer	0.000195	0.00239	CcSEcCtD
Salicylic acid—Headache—Fluorouracil—urinary bladder cancer	0.000194	0.00237	CcSEcCtD
Salicylic acid—Dysgeusia—Methotrexate—urinary bladder cancer	0.000193	0.00236	CcSEcCtD
Salicylic acid—Pruritus—Etoposide—urinary bladder cancer	0.00019	0.00233	CcSEcCtD
Salicylic acid—Nausea—Gemcitabine—urinary bladder cancer	0.000187	0.00229	CcSEcCtD
Salicylic acid—Vomiting—Cisplatin—urinary bladder cancer	0.000186	0.00228	CcSEcCtD
Salicylic acid—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000185	0.00227	CcSEcCtD
Salicylic acid—Rash—Cisplatin—urinary bladder cancer	0.000185	0.00226	CcSEcCtD
Salicylic acid—Dermatitis—Cisplatin—urinary bladder cancer	0.000185	0.00226	CcSEcCtD
Salicylic acid—Erythema—Epirubicin—urinary bladder cancer	0.000184	0.00226	CcSEcCtD
Salicylic acid—Diarrhoea—Etoposide—urinary bladder cancer	0.000184	0.00225	CcSEcCtD
Salicylic acid—Nausea—Fluorouracil—urinary bladder cancer	0.000184	0.00225	CcSEcCtD
Salicylic acid—Tinnitus—Doxorubicin—urinary bladder cancer	0.000183	0.00224	CcSEcCtD
Salicylic acid—Dysgeusia—Epirubicin—urinary bladder cancer	0.000181	0.00221	CcSEcCtD
Salicylic acid—Dizziness—Etoposide—urinary bladder cancer	0.000178	0.00217	CcSEcCtD
Salicylic acid—Nausea—Cisplatin—urinary bladder cancer	0.000174	0.00213	CcSEcCtD
Salicylic acid—Vomiting—Etoposide—urinary bladder cancer	0.000171	0.00209	CcSEcCtD
Salicylic acid—Erythema—Doxorubicin—urinary bladder cancer	0.000171	0.00209	CcSEcCtD
Salicylic acid—Rash—Etoposide—urinary bladder cancer	0.000169	0.00207	CcSEcCtD
Salicylic acid—Dermatitis—Etoposide—urinary bladder cancer	0.000169	0.00207	CcSEcCtD
Salicylic acid—Headache—Etoposide—urinary bladder cancer	0.000168	0.00206	CcSEcCtD
Salicylic acid—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000167	0.00205	CcSEcCtD
Salicylic acid—Confusional state—Methotrexate—urinary bladder cancer	0.000162	0.00199	CcSEcCtD
Salicylic acid—Nausea—Etoposide—urinary bladder cancer	0.00016	0.00195	CcSEcCtD
Salicylic acid—Anorexia—Methotrexate—urinary bladder cancer	0.000153	0.00188	CcSEcCtD
Salicylic acid—Confusional state—Epirubicin—urinary bladder cancer	0.000152	0.00186	CcSEcCtD
Salicylic acid—Oedema—Epirubicin—urinary bladder cancer	0.000151	0.00184	CcSEcCtD
Salicylic acid—ABCB1—lymph node—urinary bladder cancer	0.000148	0.00431	CbGeAlD
Salicylic acid—Anorexia—Epirubicin—urinary bladder cancer	0.000144	0.00176	CcSEcCtD
Salicylic acid—Somnolence—Methotrexate—urinary bladder cancer	0.000143	0.00175	CcSEcCtD
Salicylic acid—Dyspepsia—Methotrexate—urinary bladder cancer	0.000142	0.00173	CcSEcCtD
Salicylic acid—Confusional state—Doxorubicin—urinary bladder cancer	0.00014	0.00172	CcSEcCtD
Salicylic acid—Decreased appetite—Methotrexate—urinary bladder cancer	0.00014	0.00171	CcSEcCtD
Salicylic acid—Oedema—Doxorubicin—urinary bladder cancer	0.000139	0.00171	CcSEcCtD
Salicylic acid—Pain—Methotrexate—urinary bladder cancer	0.000138	0.00168	CcSEcCtD
Salicylic acid—Somnolence—Epirubicin—urinary bladder cancer	0.000134	0.00164	CcSEcCtD
Salicylic acid—Anorexia—Doxorubicin—urinary bladder cancer	0.000133	0.00163	CcSEcCtD
Salicylic acid—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000133	0.00162	CcSEcCtD
Salicylic acid—Dyspepsia—Epirubicin—urinary bladder cancer	0.000133	0.00162	CcSEcCtD
Salicylic acid—Decreased appetite—Epirubicin—urinary bladder cancer	0.000131	0.0016	CcSEcCtD
Salicylic acid—Pain—Epirubicin—urinary bladder cancer	0.000129	0.00158	CcSEcCtD
Salicylic acid—Constipation—Epirubicin—urinary bladder cancer	0.000129	0.00158	CcSEcCtD
Salicylic acid—Urticaria—Methotrexate—urinary bladder cancer	0.000128	0.00156	CcSEcCtD
Salicylic acid—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000124	0.00152	CcSEcCtD
Salicylic acid—Somnolence—Doxorubicin—urinary bladder cancer	0.000124	0.00152	CcSEcCtD
Salicylic acid—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000123	0.0015	CcSEcCtD
Salicylic acid—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000121	0.00148	CcSEcCtD
Salicylic acid—Urticaria—Epirubicin—urinary bladder cancer	0.00012	0.00146	CcSEcCtD
Salicylic acid—Constipation—Doxorubicin—urinary bladder cancer	0.000119	0.00146	CcSEcCtD
Salicylic acid—Pain—Doxorubicin—urinary bladder cancer	0.000119	0.00146	CcSEcCtD
Salicylic acid—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000115	0.00141	CcSEcCtD
Salicylic acid—Pruritus—Methotrexate—urinary bladder cancer	0.000114	0.00139	CcSEcCtD
Salicylic acid—Urticaria—Doxorubicin—urinary bladder cancer	0.000111	0.00135	CcSEcCtD
Salicylic acid—Diarrhoea—Methotrexate—urinary bladder cancer	0.00011	0.00135	CcSEcCtD
Salicylic acid—Pruritus—Epirubicin—urinary bladder cancer	0.000107	0.0013	CcSEcCtD
Salicylic acid—Dizziness—Methotrexate—urinary bladder cancer	0.000106	0.0013	CcSEcCtD
Salicylic acid—Diarrhoea—Epirubicin—urinary bladder cancer	0.000103	0.00126	CcSEcCtD
Salicylic acid—Vomiting—Methotrexate—urinary bladder cancer	0.000102	0.00125	CcSEcCtD
Salicylic acid—Rash—Methotrexate—urinary bladder cancer	0.000101	0.00124	CcSEcCtD
Salicylic acid—Dermatitis—Methotrexate—urinary bladder cancer	0.000101	0.00124	CcSEcCtD
Salicylic acid—Headache—Methotrexate—urinary bladder cancer	0.000101	0.00123	CcSEcCtD
Salicylic acid—Dizziness—Epirubicin—urinary bladder cancer	9.96e-05	0.00122	CcSEcCtD
Salicylic acid—Pruritus—Doxorubicin—urinary bladder cancer	9.86e-05	0.00121	CcSEcCtD
Salicylic acid—Vomiting—Epirubicin—urinary bladder cancer	9.57e-05	0.00117	CcSEcCtD
Salicylic acid—Nausea—Methotrexate—urinary bladder cancer	9.56e-05	0.00117	CcSEcCtD
Salicylic acid—Diarrhoea—Doxorubicin—urinary bladder cancer	9.53e-05	0.00117	CcSEcCtD
Salicylic acid—Rash—Epirubicin—urinary bladder cancer	9.49e-05	0.00116	CcSEcCtD
Salicylic acid—Dermatitis—Epirubicin—urinary bladder cancer	9.49e-05	0.00116	CcSEcCtD
Salicylic acid—Headache—Epirubicin—urinary bladder cancer	9.43e-05	0.00115	CcSEcCtD
Salicylic acid—Dizziness—Doxorubicin—urinary bladder cancer	9.21e-05	0.00113	CcSEcCtD
Salicylic acid—Nausea—Epirubicin—urinary bladder cancer	8.94e-05	0.00109	CcSEcCtD
Salicylic acid—Vomiting—Doxorubicin—urinary bladder cancer	8.86e-05	0.00108	CcSEcCtD
Salicylic acid—Rash—Doxorubicin—urinary bladder cancer	8.78e-05	0.00108	CcSEcCtD
Salicylic acid—Dermatitis—Doxorubicin—urinary bladder cancer	8.78e-05	0.00107	CcSEcCtD
Salicylic acid—Headache—Doxorubicin—urinary bladder cancer	8.73e-05	0.00107	CcSEcCtD
Salicylic acid—Nausea—Doxorubicin—urinary bladder cancer	8.28e-05	0.00101	CcSEcCtD
Salicylic acid—PTGS2—Metabolism—PRSS3—urinary bladder cancer	2.85e-05	0.000514	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—EP300—urinary bladder cancer	2.82e-05	0.000509	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	2.81e-05	0.000507	CbGpPWpGaD
Salicylic acid—SLC22A8—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.79e-05	0.000503	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	2.78e-05	0.000503	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—UGT2B7—urinary bladder cancer	2.78e-05	0.000502	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.75e-05	0.000497	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—SRC—urinary bladder cancer	2.74e-05	0.000495	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—TP53—urinary bladder cancer	2.7e-05	0.000487	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	2.69e-05	0.000486	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	2.69e-05	0.000485	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	2.68e-05	0.000483	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	2.67e-05	0.000482	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GSTO2—urinary bladder cancer	2.66e-05	0.000481	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—NAT1—urinary bladder cancer	2.66e-05	0.000481	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—GSTP1—urinary bladder cancer	2.65e-05	0.000479	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	2.63e-05	0.000476	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	2.62e-05	0.000474	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—NAT2—urinary bladder cancer	2.59e-05	0.000468	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	2.58e-05	0.000466	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—LIG1—urinary bladder cancer	2.58e-05	0.000465	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—CDKN1A—urinary bladder cancer	2.57e-05	0.000464	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—PTEN—urinary bladder cancer	2.57e-05	0.000463	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	2.56e-05	0.000463	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CREBBP—urinary bladder cancer	2.52e-05	0.000454	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CYP4B1—urinary bladder cancer	2.5e-05	0.000452	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	2.49e-05	0.00045	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	2.49e-05	0.000449	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—NAT1—urinary bladder cancer	2.49e-05	0.000449	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—IGF1—urinary bladder cancer	2.49e-05	0.000449	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—TYMS—urinary bladder cancer	2.47e-05	0.000445	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—PTGS2—urinary bladder cancer	2.47e-05	0.000445	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	2.45e-05	0.000442	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—EP300—urinary bladder cancer	2.45e-05	0.000442	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	2.45e-05	0.000442	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—NCOR1—urinary bladder cancer	2.44e-05	0.00044	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—GSTM1—urinary bladder cancer	2.44e-05	0.00044	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	2.44e-05	0.00044	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—IFNA2—urinary bladder cancer	2.39e-05	0.000431	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—SRC—urinary bladder cancer	2.38e-05	0.00043	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—SLC19A1—urinary bladder cancer	2.36e-05	0.000427	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—GPX1—urinary bladder cancer	2.33e-05	0.000421	CbGpPWpGaD
Salicylic acid—SLC22A6—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.33e-05	0.00042	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PRSS3—urinary bladder cancer	2.3e-05	0.000416	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—ERCC2—urinary bladder cancer	2.29e-05	0.000414	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.28e-05	0.000412	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—RHOA—urinary bladder cancer	2.28e-05	0.000411	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—TYMP—urinary bladder cancer	2.28e-05	0.000411	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	2.28e-05	0.000411	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—KRAS—urinary bladder cancer	2.27e-05	0.00041	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	2.26e-05	0.000409	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—RRM2—urinary bladder cancer	2.24e-05	0.000404	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	2.23e-05	0.000403	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	2.23e-05	0.000403	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	2.19e-05	0.000396	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.19e-05	0.000395	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	2.18e-05	0.000394	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	2.18e-05	0.000394	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—MTHFR—urinary bladder cancer	2.15e-05	0.000389	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—PTEN—urinary bladder cancer	2.15e-05	0.000388	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—MYC—urinary bladder cancer	2.13e-05	0.000385	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—ERBB2—urinary bladder cancer	2.11e-05	0.00038	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—EGFR—urinary bladder cancer	2.09e-05	0.000377	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	2.08e-05	0.000376	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—HPGDS—urinary bladder cancer	2.07e-05	0.000374	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—ENO2—urinary bladder cancer	2.07e-05	0.000374	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	2.07e-05	0.000374	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	2.06e-05	0.000372	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.06e-05	0.000372	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—NAT2—urinary bladder cancer	2.06e-05	0.000372	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	2.06e-05	0.000371	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—EP300—urinary bladder cancer	2.05e-05	0.00037	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	2.05e-05	0.00037	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PRSS3—urinary bladder cancer	2.02e-05	0.000364	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—TP53—urinary bladder cancer	2.02e-05	0.000364	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—GSTT1—urinary bladder cancer	2.01e-05	0.000363	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CXCL8—urinary bladder cancer	2e-05	0.000361	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.98e-05	0.000357	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	1.97e-05	0.000356	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—KRAS—urinary bladder cancer	1.97e-05	0.000356	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—ENO2—urinary bladder cancer	1.96e-05	0.000355	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	1.93e-05	0.000349	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—HRAS—urinary bladder cancer	1.93e-05	0.000348	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—IL2—urinary bladder cancer	1.91e-05	0.000345	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	1.91e-05	0.000345	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	1.91e-05	0.000344	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	1.89e-05	0.00034	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—RBX1—urinary bladder cancer	1.86e-05	0.000336	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CCND1—urinary bladder cancer	1.86e-05	0.000336	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.85e-05	0.000333	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—TYMP—urinary bladder cancer	1.84e-05	0.000332	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.83e-05	0.000331	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	1.82e-05	0.000328	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—MMP9—urinary bladder cancer	1.81e-05	0.000326	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CDKN1A—urinary bladder cancer	1.8e-05	0.000325	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—PTEN—urinary bladder cancer	1.8e-05	0.000324	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	1.79e-05	0.000324	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—RRM2—urinary bladder cancer	1.78e-05	0.000321	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.77e-05	0.000319	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	1.77e-05	0.000319	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PPARG—urinary bladder cancer	1.75e-05	0.000315	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—EP300—urinary bladder cancer	1.71e-05	0.000309	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—PLAU—urinary bladder cancer	1.69e-05	0.000306	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—CREBBP—urinary bladder cancer	1.68e-05	0.000303	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—HRAS—urinary bladder cancer	1.68e-05	0.000302	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—NQO1—urinary bladder cancer	1.67e-05	0.000302	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—JAG1—urinary bladder cancer	1.67e-05	0.000301	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—SRC—urinary bladder cancer	1.67e-05	0.000301	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—NAT2—urinary bladder cancer	1.67e-05	0.000301	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—HPGDS—urinary bladder cancer	1.65e-05	0.000297	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—ENO2—urinary bladder cancer	1.65e-05	0.000297	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.64e-05	0.000295	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.62e-05	0.000293	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—TYMP—urinary bladder cancer	1.61e-05	0.000291	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—GSTT1—urinary bladder cancer	1.6e-05	0.000288	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	1.58e-05	0.000286	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.57e-05	0.000284	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	1.55e-05	0.00028	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.51e-05	0.000273	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—TYMP—urinary bladder cancer	1.51e-05	0.000272	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—MYC—urinary bladder cancer	1.49e-05	0.00027	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	1.47e-05	0.000266	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	1.46e-05	0.000264	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—EGFR—urinary bladder cancer	1.46e-05	0.000264	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—NAT2—urinary bladder cancer	1.46e-05	0.000263	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.45e-05	0.000261	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—RRM2—urinary bladder cancer	1.44e-05	0.000259	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.41e-05	0.000255	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—CREBBP—urinary bladder cancer	1.4e-05	0.000252	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—GSTP1—urinary bladder cancer	1.39e-05	0.000252	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—KRAS—urinary bladder cancer	1.38e-05	0.000249	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—IGF1—urinary bladder cancer	1.38e-05	0.000249	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PTGS2—urinary bladder cancer	1.37e-05	0.000248	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—NAT2—urinary bladder cancer	1.36e-05	0.000246	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.35e-05	0.000243	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—HPGDS—urinary bladder cancer	1.33e-05	0.00024	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—ENO2—urinary bladder cancer	1.33e-05	0.00024	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—NQO1—urinary bladder cancer	1.33e-05	0.000239	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.32e-05	0.000239	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.3e-05	0.000235	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—TYMS—urinary bladder cancer	1.3e-05	0.000234	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GSTT1—urinary bladder cancer	1.29e-05	0.000233	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—NCOR1—urinary bladder cancer	1.28e-05	0.000231	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—GSTM1—urinary bladder cancer	1.28e-05	0.000231	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.27e-05	0.000229	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—RHOA—urinary bladder cancer	1.26e-05	0.000228	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—RRM2—urinary bladder cancer	1.26e-05	0.000227	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—TP53—urinary bladder cancer	1.23e-05	0.000221	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—GPX1—urinary bladder cancer	1.23e-05	0.000221	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—NCOR1—urinary bladder cancer	1.21e-05	0.000219	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.21e-05	0.000218	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—ERCC2—urinary bladder cancer	1.2e-05	0.000217	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PTEN—urinary bladder cancer	1.2e-05	0.000216	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—RRM2—urinary bladder cancer	1.18e-05	0.000212	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—HRAS—urinary bladder cancer	1.17e-05	0.000212	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—HPGDS—urinary bladder cancer	1.17e-05	0.000211	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ENO2—urinary bladder cancer	1.17e-05	0.000211	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—EP300—urinary bladder cancer	1.14e-05	0.000206	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—ERCC2—urinary bladder cancer	1.14e-05	0.000206	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—MTHFR—urinary bladder cancer	1.13e-05	0.000204	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GSTT1—urinary bladder cancer	1.13e-05	0.000204	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.12e-05	0.000203	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—GSTP1—urinary bladder cancer	1.11e-05	0.0002	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	1.09e-05	0.000197	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ENO2—urinary bladder cancer	1.09e-05	0.000197	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.08e-05	0.000196	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—NQO1—urinary bladder cancer	1.07e-05	0.000194	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—MTHFR—urinary bladder cancer	1.07e-05	0.000194	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.07e-05	0.000193	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—TERT—urinary bladder cancer	1.07e-05	0.000193	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—IL2—urinary bladder cancer	1.06e-05	0.000191	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.06e-05	0.000191	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	1.06e-05	0.000191	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.04e-05	0.000188	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.04e-05	0.000188	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—TYMS—urinary bladder cancer	1.03e-05	0.000186	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—NCOR1—urinary bladder cancer	1.02e-05	0.000183	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—GSTM1—urinary bladder cancer	1.02e-05	0.000183	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—FGFR3—urinary bladder cancer	9.82e-06	0.000177	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—GPX1—urinary bladder cancer	9.74e-06	0.000176	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—ERCC2—urinary bladder cancer	9.56e-06	0.000173	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—EP300—urinary bladder cancer	9.51e-06	0.000172	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—NQO1—urinary bladder cancer	9.4e-06	0.00017	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—SRC—urinary bladder cancer	9.25e-06	0.000167	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PPARG—urinary bladder cancer	9.18e-06	0.000166	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	9.08e-06	0.000164	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—MTHFR—urinary bladder cancer	8.99e-06	0.000162	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GSTP1—urinary bladder cancer	8.95e-06	0.000162	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—CREBBP—urinary bladder cancer	8.82e-06	0.000159	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—NQO1—urinary bladder cancer	8.78e-06	0.000159	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	8.66e-06	0.000156	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	8.52e-06	0.000154	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CREBBP—urinary bladder cancer	8.36e-06	0.000151	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—TYMS—urinary bladder cancer	8.32e-06	0.00015	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GSTM1—urinary bladder cancer	8.23e-06	0.000148	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—NCOR1—urinary bladder cancer	8.23e-06	0.000148	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GPX1—urinary bladder cancer	7.88e-06	0.000142	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GSTP1—urinary bladder cancer	7.84e-06	0.000142	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—ERCC2—urinary bladder cancer	7.73e-06	0.00014	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—KRAS—urinary bladder cancer	7.66e-06	0.000138	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—RHOA—urinary bladder cancer	7.56e-06	0.000136	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	7.43e-06	0.000134	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	7.33e-06	0.000132	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—TYMS—urinary bladder cancer	7.29e-06	0.000132	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PPARG—urinary bladder cancer	7.29e-06	0.000131	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—MTHFR—urinary bladder cancer	7.27e-06	0.000131	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PTGS2—urinary bladder cancer	7.22e-06	0.00013	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—NCOR1—urinary bladder cancer	7.21e-06	0.00013	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GSTM1—urinary bladder cancer	7.21e-06	0.00013	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	7.09e-06	0.000128	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CREBBP—urinary bladder cancer	7e-06	0.000126	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—ERBB2—urinary bladder cancer	7e-06	0.000126	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GPX1—urinary bladder cancer	6.9e-06	0.000125	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—TYMS—urinary bladder cancer	6.81e-06	0.000123	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—TP53—urinary bladder cancer	6.81e-06	0.000123	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ERCC2—urinary bladder cancer	6.78e-06	0.000122	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	6.73e-06	0.000122	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	6.73e-06	0.000122	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—HRAS—urinary bladder cancer	6.51e-06	0.000117	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GPX1—urinary bladder cancer	6.45e-06	0.000116	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—MTHFR—urinary bladder cancer	6.37e-06	0.000115	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	6.33e-06	0.000114	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PTEN—urinary bladder cancer	6.3e-06	0.000114	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—EP300—urinary bladder cancer	6e-06	0.000108	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CDKN1A—urinary bladder cancer	5.98e-06	0.000108	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PTEN—urinary bladder cancer	5.97e-06	0.000108	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	5.95e-06	0.000107	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PPARG—urinary bladder cancer	5.89e-06	0.000106	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—EP300—urinary bladder cancer	5.69e-06	0.000103	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CREBBP—urinary bladder cancer	5.66e-06	0.000102	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—SRC—urinary bladder cancer	5.54e-06	9.99e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PPARG—urinary bladder cancer	5.16e-06	9.32e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PTEN—urinary bladder cancer	5e-06	9.02e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CREBBP—urinary bladder cancer	4.96e-06	8.95e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—MYC—urinary bladder cancer	4.96e-06	8.95e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—EGFR—urinary bladder cancer	4.85e-06	8.76e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PPARG—urinary bladder cancer	4.82e-06	8.71e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—EP300—urinary bladder cancer	4.77e-06	8.6e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PTGS2—urinary bladder cancer	4.64e-06	8.37e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	4.64e-06	8.37e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—KRAS—urinary bladder cancer	4.58e-06	8.27e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PTGS2—urinary bladder cancer	4.06e-06	7.33e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PTEN—urinary bladder cancer	4.04e-06	7.3e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—HRAS—urinary bladder cancer	3.9e-06	7.03e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—EP300—urinary bladder cancer	3.86e-06	6.96e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	3.8e-06	6.85e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PTEN—urinary bladder cancer	3.54e-06	6.39e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—EP300—urinary bladder cancer	3.38e-06	6.1e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PTEN—urinary bladder cancer	3.31e-06	5.97e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—EP300—urinary bladder cancer	3.16e-06	5.7e-05	CbGpPWpGaD
